RPG LifeScience.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE105J01010
  • NSEID: RPGLIFE
  • BSEID: 532983
INR
2,778.10
-72.1 (-2.53%)
BSENSE

Jul 30, 04:04 PM

BSE+NSE Vol: 24.27 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
195.69
176.89
180.03
181.68
168.92
143.09
172.71
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
195.69
176.89
180.03
181.68
168.92
143.09
172.71
Raw Material Cost
37.68
36.43
34.79
32.72
32.04
26.89
30.19
Purchase of Finished goods
39.53
22.63
43.63
38.78
33.06
21.22
22.70
(Increase) / Decrease In Stocks
-9.06
1.53
-13.52
-4.92
-5.08
0.61
3.22
Employee Cost
37.76
36.30
35.32
36.16
33.70
31.60
28.71
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
46.49
47.17
40.05
39.91
39.73
37.28
38.73
Total Expenditure (Excl Depreciation)
152.40
144.06
140.27
142.65
133.45
117.60
123.55
Operating Profit (PBDIT) excl Other Income
43.29
32.83
39.76
39.03
35.47
25.49
49.16
Other Income
4.70
12.40
3.41
4.54
5.23
5.06
3.31
Operating Profit (PBDIT)
47.99
45.23
43.17
43.57
40.70
30.55
52.47
Interest
0.63
0.39
0.25
0.12
0.13
0.18
0.12
Exceptional Items
0.00
1.10
-8.42
11.22
0.00
109.90
0.00
Gross Profit (PBDT)
47.36
45.94
34.50
54.67
40.57
140.27
52.35
Depreciation
5.90
5.74
5.38
5.22
5.14
5.37
5.46
Profit Before Tax
41.46
40.20
29.12
49.45
35.43
134.90
46.89
Tax
10.70
10.30
6.99
12.60
9.14
17.55
11.96
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
30.76
29.90
22.13
36.85
26.29
117.35
34.93
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
30.76
29.90
22.13
36.85
26.29
117.35
34.93
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
30.76
29.90
22.13
36.85
26.29
117.35
34.93
Equity Capital
13.23
13.23
13.23
13.23
13.23
13.23
13.23
Face Value
8.0
8.0
8.0
8.0
8.0
8.0
8.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
18.6
18.08
13.38
22.28
15.9
70.96
21.12
Diluted Earnings per share
18.6
18.08
13.38
22.28
15.9
70.96
21.12
Operating Profit Margin (Excl OI)
22.12%
18.56%
22.09%
21.48%
21.0%
17.81%
28.46%
Gross Profit Margin
24.2%
25.97%
19.16%
30.09%
24.02%
98.03%
30.31%
PAT Margin
15.72%
16.9%
12.29%
20.28%
15.56%
82.01%
20.22%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2026 is 10.63% vs -1.74% in Mar 2026

stock-summary

Standalone Net Profit

QoQ Growth in quarter ended Jun 2026 is 2.24% vs 35.11% in Mar 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is 32.58% vs -17.33% in Mar 2026

stock-summary

Interest

QoQ Growth in quarter ended Jun 2026 is 61.54% vs 56.00% in Mar 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

Compare Quarterly Results Of RPG LifeScience. With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
195.69
256.99
-61.30
-23.85%
Other Operating Income
0.00
0.00
0.00
Total Operating income
195.69
256.99
-61.30
-23.85%
Raw Material Cost
37.68
111.26
-73.58
-66.13%
Purchase of Finished goods
39.53
18.21
21.32
117.08%
(Increase) / Decrease In Stocks
-9.06
-16.01
6.95
43.41%
Employee Cost
37.76
36.14
1.62
4.48%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
46.49
62.95
-16.46
-26.15%
Total Expenditure (Excl Depreciation)
152.40
212.55
-60.15
-28.30%
Operating Profit (PBDIT) excl Other Income
43.29
44.44
-1.15
-2.59%
Other Income
4.70
11.16
-6.46
-57.89%
Operating Profit (PBDIT)
47.99
55.60
-7.61
-13.69%
Interest
0.63
2.01
-1.38
-68.66%
Exceptional Items
0.00
0.03
-0.03
-100.00%
Gross Profit (PBDT)
47.36
53.62
-6.26
-11.67%
Depreciation
5.90
8.67
-2.77
-31.95%
Profit Before Tax
41.46
44.95
-3.49
-7.76%
Tax
10.70
7.95
2.75
34.59%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
30.76
37.00
-6.24
-16.86%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
30.76
37.00
-6.24
-16.86%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
1.42
-1.42
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
30.76
35.58
-4.82
-13.55%
Equity Capital
13.23
10.58
2.65
25.05%
Face Value
8.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
18.60
3.36
15.24
453.57%
Diluted Earnings per share
18.60
3.28
15.32
467.07%
Operating Profit Margin (Excl OI)
22.12%
17.29%
0.00
4.83%
Gross Profit Margin
24.20%
20.86%
0.00
3.34%
PAT Margin
15.72%
14.40%
0.00
1.32%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 195.69 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is 10.63% vs -1.74% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 15.85% vs 2.12% in Jun 2025

Quarterly - Standalone Net Profit
Standalone Net Profit 30.57 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is 2.24% vs 35.11% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 16.28% vs -1.76% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 43.58 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is 32.58% vs -17.33% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 22.86% vs -9.21% in Jun 2025

Quarterly - Interest
Interest 0.63 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is 61.54% vs 56.00% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 384.62% vs -13.33% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 22.27%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025